Though recent reports link SARS-CoV-2 infections with hyper-inflammatory states in
children, most children experience no/mild symptoms, and hospitalization and mortality rates …

The COVID‐19 pandemic transformed everyday life, but the implications were most
impactful for vulnerable populations, including patients with chronic pain. Moreover …

Objective To provide guidance to rheumatology providers on the use of coronavirus disease
2019 (COVID‐19) vaccines for patients with rheumatic and musculoskeletal diseases …

To update the European League Against Rheumatism (EULAR) recommendations for
vaccination in adult patients with autoimmune inflammatory rheumatic diseases (AIIRD) …

Objectives Recent insights supporting the safety of live-attenuated vaccines and novel
studies on the immunogenicity of vaccinations in the era of biological disease-modifying …

Objective To provide guidance to rheumatology providers on the use of COVID‐19 vaccines
for patients with rheumatic and musculoskeletal diseases (RMDs). Methods A task force was …

Abstract The Coronavirus Disease 2019 (COVID-19) pandemic influenced the management
of patients with anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis. A paucity …

Objective To provide guidance to rheumatology providers on the use of COVID‐19 vaccines
for patients with rheumatic and musculoskeletal diseases (RMDs). Methods A task force was …

Background and aims: Our first objective was to evaluate the immune response to the
adjuvanted 2009 A/H1N1 pandemic (pH1N1) vaccine in inflammatory bowel disease (IBD) …

Introduction An adjuvanted pandemic H1N1 influenza (pH1N1) vaccine (Pandemrix®) was
reported as highly immunogenic resulting in seroconversion in 77 to 94% of adults after …